GLP-1 Cost in Delaware (2026): Tirzepatide & Semaglutide Prices, Wilmington to Smyrna

Nobody in Delaware should pay list price for a GLP-1 in 2026, and almost nobody has to: verified telehealth puts compounded tirzepatide at $215–$597/month all-in and semaglutide at $133–$299 across the state, brand injectables at $299–$449, and covered copays at $25–$50 — the same menu in Wilmington, Dover, and Middletown.

Statewide, the pattern holds from Wilmington to Smyrna: prescriber licensed for Delaware, pharmacy licensed for Delaware, refrigerated box on your porch — while local programs near Dover bill $400–$700/month for the identical compounded molecule plus a waiting room.

Cheapest verified in Delaware, as everywhere we can source-check: NexLife, $215 flat all-in — the rare program that names its six-pharmacy network and prices the whole dose ladder identically — with 12-month pricing at $186 and a $145–$165 semaglutide line that leads that board’s value tier too. That flat structure prices Newark and Smyrna identically — the whole point of ranking on the all-in figure.

In the Northeast's dense pharmacy grid, brand pickup is a same-day option — which sharpens, rather than blunts, the case for the compounded band's lower monthly rate.

The value cluster after the floor runs $258–$299 (Yucca, IVIM, Mochi, ShedRx, Found) with terms that matter — six-month plans, memberships, prepays — all normalized on the ranking page; semaglutide’s verified band starts at $133 and the board sorts it.

Before paying cash in Delaware: check coverage (increasingly generous — $25–$50 with cards or Medicare; indication side doors via OSA and cardiovascular labels), then verify the quote is the maintenance-dose, all-in, standing figure — the exact normalization our methodology applies before ranking anything.

The rest of the Delaware picture — stat cards, city notes, insurance and annual math — is in the complete Delaware guide; sources and capture dates ship in the dataset.